End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
71.41 CNY | +1.00% | -4.89% | -26.23% |
Apr. 25 | Micro-Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | Tranche Update on Micro-Tech Co.,Ltd's Equity Buyback Plan announced on February 5, 2024. | CI |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-26.23% | 1.84B | C | ||
-5.43% | 182B | C+ | ||
+4.30% | 114B | C | ||
-3.09% | 68.38B | A | ||
+5.86% | 52.46B | B- | ||
+8.15% | 44.25B | B- | ||
+7.52% | 43.55B | B+ | ||
+25.54% | 32.69B | B | ||
+17.85% | 26.73B | A- | ||
+1.00% | 25.79B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 688029 Stock
- Ratings Micro-Tech (Nanjing) Co.,Ltd